Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 17, 2026

S&P 500 and Nasdaq 100 Soar to Record Highs as Middle East Tensions Ease

View original at nasdaq.com
S&P 500 and Nasdaq 100 Soar to Record Highs as Middle East Tensions Ease The S&P 500 Index ($SPX) (SPY) today is up +1.28%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +2.07%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.326%…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The ECB needs to stay vigilant to potential inflation risks from the Iran war, but there is no obvious case to raise rates

    60% confidence
  • June is a better moment than April to decide whether an ECB interest rate response to the Iran war is necessary

    60% confidence
  • Q1 S&P 500 earnings projected to climb +12% y/y, and stripping out the technology sector, Q1 earnings are projected to increase around +3%, the weakest in two years

    60% confidence
  • President Trump might travel to Pakistan if a deal with Iran is clinched

    60% confidence
  • Iran made key concessions in an ongoing negotiation to end the seven-week war

    60% confidence
  • The US and Iran are negotiating over a plan to end the war, with one element under discussion being that the US would release $20 billion in frozen Iranian assets in return for Iran giving up its stockpile of enriched uranium

    60% confidence
  • The US naval blockade in the Strait of Hormuz will remain in full force until a deal is fully agreed

    60% confidence
  • Risks to the price outlook are tilted to the upside, especially in the near term, while the medium-term implications will depend on the intensity and duration of the war

    60% confidence

Data points we hold from this source

Exxon Mobil Corporation · stock return-6 percent

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com
S&P 500 and Nasdaq 100 Soar to Record Highs as Middle East Tensions Ease — Source | Via News | ViaNews Market